2022
DOI: 10.1016/j.brainres.2022.148014
|View full text |Cite
|
Sign up to set email alerts
|

Cerebral venous hemodynamic responses in a mouse model of traumatic brain injury

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 51 publications
0
3
0
Order By: Relevance
“…After severe trauma and surgical manipulation of the skull, the loss of natural brain architecture may lead to CSF [ 36 ] and venous blood [ 37 , 38 ] transit impairment. Therefore, the buffering mechanisms of the compensatory reserve, such as CSF displacement toward cervical cisterns and large venous sinuses emptying their volumes to extracranial veins are limited [ 22 , 39 ].…”
Section: Discussionmentioning
confidence: 99%
“…After severe trauma and surgical manipulation of the skull, the loss of natural brain architecture may lead to CSF [ 36 ] and venous blood [ 37 , 38 ] transit impairment. Therefore, the buffering mechanisms of the compensatory reserve, such as CSF displacement toward cervical cisterns and large venous sinuses emptying their volumes to extracranial veins are limited [ 22 , 39 ].…”
Section: Discussionmentioning
confidence: 99%
“…The modified neurological severity score (mNSS) and Garcia score were used to detect neurological impairments in mice [14]. In the mNSS test, the higher the score, the worse is the neurological function.…”
Section: Behavioral Assessmentmentioning
confidence: 99%
“…During the acute and subacute phases of TBI, the formation of neovascularization in the penumbra region can enhance oxygen and nutrient supply to the injured tissue, thereby promoting TBI recovery and improving brain function [8][9][10]. Consequently, the early establishment of robust collateral circulation is crucial for the recovery of brain injuries, and promoting angiogenesis may represent a potential therapeutic target for TBI [11]. Orexin-A has been identified as a novel angiogenic peptide, promoting blood vessel formation by activating the MEK/ERK1/2 signaling pathway through Orexin-A receptor activation [12].…”
Section: Introductionmentioning
confidence: 99%